- PZU reported a net income of 5.34 billion zloty for the fiscal year, which, while being a 7.6% decrease compared to the previous year, exceeded the market estimate of 5.06 billion zloty.
- The company’s insurance sales came in at 29.42 billion zloty, surpassing the expected 29.08 billion zloty.
- Operating profit was reported at 15.70 billion zloty, showing a 2.7% decrease year-over-year but still beating the estimate of 15.04 billion zloty.
- PZU has received 9 buy ratings, 2 hold ratings, and no sell ratings from analysts.
A look at Powszechny Zaklad Ubezpieczen Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 4 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
When analyzing the long-term outlook for Powszechny Zaklad Ubezpieczen, the Smartkarma Smart Scores provide valuable insights. With a high Momentum score of 5, the company appears to be experiencing strong positive price trends that may continue into the future. Additionally, both the Dividend and Growth scores are solid at 4, indicating stability and potential for expansion. However, the Value and Resilience scores stand at 3, suggesting room for improvement in terms of value proposition and ability to weather unforeseen challenges.
Powszechny Zaklad Ubezpieczen SA focuses on property and casualty insurance, offering a variety of non-life insurance products such as fire and automobile insurance. The company also has a division dedicated to providing life insurance. Overall, the company’s Smart Scores highlight a favorable outlook in terms of momentum, dividend, and growth potential, although areas such as value and resilience could benefit from further attention to enhance the company’s long-term prospects.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
